ibs and glp 1 Can a patient with a history of gastrointestinal issues, such as Irritable Bowel Syndrome (IBS), possibly obesity or type 2 diabetes, take teriziptide with Glucagon-Like Peptide-1 (GLP-1)? GLP-1 Receptor Agonists in Obese

Viking's Dual Agonist Drug Shows Potential As It Moves Through Trial Process A much smaller firm than Eli Lilly, Viking Therapeutics Inc

GLP-1 Impact One of the most notable drivers of peptide interest has been the surge in GLP-1 drug prescriptions

Adjustments in dosage may be needed based on blood sugar levels, including your A1C levels

They work in two key ways: Slow down stomach emptying Food stays in your stomach longer, making you feel full Send signals to your brain They tell the hunger centers in your brain to calm down Popular GLP-1 Medications The most common GLP-1 medications include: Semaglutide (Ozempic, Wegovy) Tirzepatide (Mounjaro, Zepbound) Liraglutide (Saxenda, Victoza) Dulaglutide (Trulicity) These medications help with both diabetes management and weight management by targeting appetite control

BCBS of Vermont no longer covers any GLP-1 receptor agonists FDA-approved for weight loss as of January 1, 2026